Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control
Crossref DOI link: https://doi.org/10.1007/s00592-015-0721-4
Published Online: 2015-02-27
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Barchetta, Ilaria
Guglielmi, Chiara
Bertoccini, Laura
Calella, Damiano
Manfrini, Silvia
Secchi, Chiara
Pozzilli, Paolo
Cavallo, Maria Gisella
Text and Data Mining valid from 2015-02-27